These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


245 related items for PubMed ID: 24664

  • 1. Effects of restoring lethally irradiated mice with anti-Thy 1.2-treated bone marrow: graft-vs-host, host-vs-graft, and mitogen reactivity.
    Norin AJ, Emeson EE.
    J Immunol; 1978 Mar; 120(3):754-8. PubMed ID: 24664
    [Abstract] [Full Text] [Related]

  • 2. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST, Wren SM, Bluestone JA, Barbieri SA, Stephany D, Sachs DH.
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [Abstract] [Full Text] [Related]

  • 3. Antilymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added complement.
    Thierfelder S, Cobbold S, Kummer U, Waldmann H, Schuh R.
    Exp Hematol; 1985 Oct; 13(9):948-55. PubMed ID: 2864278
    [Abstract] [Full Text] [Related]

  • 4. Long-term survival of murine allogeneic bone marrow chimeras: effect of anti-lymphocyte serum and bone marrow dose.
    Norin AJ, Emeson EE, Veith FJ.
    J Immunol; 1981 Feb; 126(2):428-32. PubMed ID: 7451985
    [Abstract] [Full Text] [Related]

  • 5. The graft-versus-host reaction and immune function. III. Functional pre-T cells in the bone marrow of graft-versus-host-reactive mice displaying T cell immunodeficiency.
    Seddik M, Seemayer TA, Lapp WS.
    Transplantation; 1986 Feb; 41(2):238-42. PubMed ID: 3484849
    [Abstract] [Full Text] [Related]

  • 6. Effect of the treatment of parental cells in vitro with anti-T antibody on bone marrow transplantation in F1 hybrid mice.
    Hrubá A, Paluska E, Fricová V, Fiala J.
    Folia Biol (Praha); 1980 Feb; 26(5):338-50. PubMed ID: 7002637
    [Abstract] [Full Text] [Related]

  • 7. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets.
    Hirano M, Arase H, Arase-Fukushi N, Ogasawara K, Iwabuchi K, Miyazaki T, Good RA, Onoé K.
    Cell Immunol; 1993 Oct 01; 151(1):118-32. PubMed ID: 8402923
    [Abstract] [Full Text] [Related]

  • 8. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
    Peres A, Nestel FP, Seemayer TA, Lapp WS.
    J Immunol; 1986 Dec 01; 137(11):3420-7. PubMed ID: 3537120
    [Abstract] [Full Text] [Related]

  • 9. Use of lymphokine-activated killer cells to prevent bone marrow graft rejection and lethal graft-vs-host disease.
    Azuma E, Yamamoto H, Kaplan J.
    J Immunol; 1989 Sep 01; 143(5):1524-9. PubMed ID: 2668409
    [Abstract] [Full Text] [Related]

  • 10. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
    Glass B, Uharek L, Gaska T, Gassmann W, Löffler H, Müller-Ruchholtz W.
    Bone Marrow Transplant; 1993 Sep 01; 12 Suppl 3():S41-7. PubMed ID: 8124257
    [Abstract] [Full Text] [Related]

  • 11. Effects of T cell depletion in radiation bone marrow chimeras. III. Characterization of allogeneic bone marrow cell populations that increase allogeneic chimerism independently of graft-vs-host disease in mixed marrow recipients.
    Sykes M, Chester CH, Sundt TM, Romick ML, Hoyles KA, Sachs DH.
    J Immunol; 1989 Dec 01; 143(11):3503-11. PubMed ID: 2584703
    [Abstract] [Full Text] [Related]

  • 12. Bone marrow transplantation across major histocompatability barriers in mice. III. Treatment of donor grafts with monoclonal antibodies directed against Lyt determinants.
    Vallera DA, Soderling CC, Kersey JH.
    J Immunol; 1982 Feb 01; 128(2):871-5. PubMed ID: 6172513
    [Abstract] [Full Text] [Related]

  • 13. Role of the thymus in control of autoreactivity or allotolerance in syngeneic and allogeneic bone marrow chimeras treated with bacterial adjuvants.
    Taniguchi K, Gondo H, Nomoto K.
    J Immunol; 1984 Oct 01; 133(4):1735-9. PubMed ID: 6088626
    [Abstract] [Full Text] [Related]

  • 14. Strain difference in the radiosensitivity of immunocompetent cells and its influence on the residual host-vs-graft reaction in lethally irradiated mice grafted with semiallogeneic bone marrow.
    Sado T, Kamisaku H, Kubo E.
    J Immunol; 1985 Feb 01; 134(2):704-10. PubMed ID: 3880789
    [Abstract] [Full Text] [Related]

  • 15. The graft-versus-host reaction and immune function. II. Recruitment of pre-T-cells in vivo by graft-versus-host-induced dysplastic thymuses following irradiation and bone marrow treatment.
    Seddik M, Seemayer TA, Lapp WS.
    Transplantation; 1984 Mar 01; 37(3):286-90. PubMed ID: 6142550
    [Abstract] [Full Text] [Related]

  • 16. Abrogation of bone marrow allograft resistance in mice by increased total body irradiation correlates with eradication of host clonable T cells and alloreactive cytotoxic precursors.
    Schwartz E, Lapidot T, Gozes D, Singer TS, Reisner Y.
    J Immunol; 1987 Jan 15; 138(2):460-5. PubMed ID: 3098843
    [Abstract] [Full Text] [Related]

  • 17. Spontaneous and IL-2-induced anti-leukemic and anti-host effects against tumor- and host-specific alloantigens.
    Cohen P, Vourka-Karussis U, Weiss L, Slavin S.
    J Immunol; 1993 Nov 01; 151(9):4803-10. PubMed ID: 8409438
    [Abstract] [Full Text] [Related]

  • 18. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
    Davenport C, George T, Devora GA, Morris MA, Gordon BE, Kumar V, Bennett M.
    Biol Blood Marrow Transplant; 1997 Dec 01; 3(6):294-303. PubMed ID: 9502296
    [Abstract] [Full Text] [Related]

  • 19. Treatment of BCL1 leukemia by transplantation of low density fractions of allogeneic bone marrow and spleen cells.
    Palathumpat V, Holm B, Dejbakhsh-Jones S, Strober S.
    J Immunol; 1992 May 15; 148(10):3319-26. PubMed ID: 1578152
    [Abstract] [Full Text] [Related]

  • 20. Regulation of cell-mediated cytotoxicity. III. Synergism of cortico-resistant with anti-thymocyte serum-resistant splenic T cells in the generation of cytotoxic lymphocytes in graft-vs-host reactions.
    Babu UM, Sabbadini E.
    J Immunol; 1977 Aug 15; 119(2):781-5. PubMed ID: 18543
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.